Skip to content
WeighLab
Menu
Ranked #28 · Grade B−

Henry Meds review

A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.

Visit Henry Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

Semaglutide · modeled / year

$2,988

Tirzepatide · modeled / year

$4,188

The Index scorecard

Henry Meds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month74/100
Price Transparency86/100
Nationwide Access84/100
Formulation Options80/100
Clinical Oversight83/100
Contract Flexibility84/100

Where the value is

  • Simple, transparent flat-fee model that's easy to model
  • Well-established brand
  • Both molecules disclosed

The tradeoffs

  • Higher per-month cost than many newer entrants weakens value
  • Compounded only

The bottom line

Best for: People who want a simple, well-known flat-fee program and will pay a premium for the brand. A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.

Ranked #28 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Henry Meds.

The 24 programs nearest this one

Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard